Delivery Order SPE2DB20D1100-SPE2DB25FD2Q1

Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $2,757.91. The contract is a firm fixed price, non-set-aside, delivery order contract with a performance period ending on June 16, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $1,108.77 and a completion date of January 28, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,431.02 and is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a period of performance running through June 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a respiratory medication, and has a ceiling value of $73,209.55. The contract is a firm fixed-price, delivery order contract with a period of performance through January 7, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription medication. The fixed-price contract has a ceiling value of $2,695.14 and a period of performance extending through May 20, 2025. The contract is not set aside for any specific business designation. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,683.00, is for the delivery of 4,568,173,927 units of the ADVAIR HFA 115-21 MCG INHALER 12GM medication. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 8, 2025. AmerisourceBergen Drug Corp, a for-profit organization based in Conshohocken, Pennsylvania, holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. The contract, with a ceiling value of $14,555.07, is a firm-fixed-price delivery order with an ultimate completion date of August 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,920.85 and an ultimate completion date of October 21, 2024. It is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. The contract is a firm fixed-price delivery order and was not set aside for any specific business category....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription medication. The contract has a firm fixed price of $1,870.50 and a completion date of June 26, 2025. The contract is not set-aside and was openly competed. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription medication. The contract has a ceiling value of $3,070.68 and is a firm fixed-price delivery order, with a period of performance through May 6, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FD2Q1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $8,353.86 and a performance period through July 2025. The contract is firm fixed price and not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 10/6/25, 12:47 PM